Ibrutinib for Chronic Lymphocytic Leukemia.
Willamette Valley Cancer Institute and Research Center, Eugene, OR.
Jeff P
JP
Sharman
University of Pennsylvania, Philadelphia, PA anthony.mato@uphs.upenn.edu.
Anthony R
AR
Mato
University of Texas M.D. Anderson Cancer Center, Houston, TX.
Michael J
MJ
Keating
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011720:Pyrazoles; D011743:Pyrimidines; D002699:Chlorambucil